NGFR and Alzheimer disease: Another experimental study further established the role of targeting p75NTR in AD using fluorescence resonance energy transfer- (FRET-) based technology to investigate oligomeric Aβ interactions with the extracellular domain of p75NTR and concluded that p75NTR is required for Aβ induced deleterious signalling and neurodegeneration [13].